Page last updated: 2024-10-24

regulation of isotype switching

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of isotype switching. [GOC:ai]

Isotype switching is a crucial biological process that alters the effector function of antibodies produced by B cells. It involves a DNA rearrangement event where the constant region of the antibody heavy chain gene is switched from one isotype to another, such as from IgM to IgG, IgE, or IgA. This switch is influenced by a variety of factors, including the nature of the antigen encountered, the cytokine environment, and the stage of B cell development.

The process is initiated by the activation of B cells by antigen and helper T cells. Upon activation, B cells undergo proliferation and differentiation, giving rise to plasma cells that produce antibodies. During this differentiation process, the heavy chain locus undergoes a series of DNA recombination events that result in the expression of different isotypes of antibody.

This recombination process involves specific DNA sequences known as switch regions (S regions), located upstream of each constant region gene. The S regions contain repetitive sequences that are recognized by specific enzymes, including the enzyme activation-induced cytidine deaminase (AID). AID acts on the S regions, introducing DNA breaks that are subsequently repaired by non-homologous end joining (NHEJ).

During the recombination process, one S region upstream of the existing constant region gene is targeted for cleavage, and another S region upstream of the desired new constant region gene is also cleaved. The two DNA segments between these breaks are then ligated together, resulting in the deletion of the intervening DNA, including the original constant region gene. This process effectively switches the antibody isotype.

The specific isotype that is switched to is influenced by the cytokine environment. For example, the cytokine interferon-gamma (IFN-γ) promotes switching to IgG2a and IgG3, while IL-4 promotes switching to IgE. The choice of isotype is critical for the appropriate immune response, as different isotypes mediate distinct effector functions.

IgG antibodies provide long-lasting humoral immunity, IgE mediates allergic reactions, and IgA is involved in mucosal immunity. Therefore, the regulation of isotype switching ensures that the appropriate type of antibody is produced to effectively combat specific pathogens and protect the host from infection.

Overall, isotype switching is a complex but essential process that allows B cells to adapt their antibody repertoire to the specific challenges posed by different pathogens. It involves precise DNA recombination events, influenced by various factors, ultimately leading to the generation of antibodies with diverse effector functions.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Interleukin-10An interleukin-10 that is encoded in the genome of human. [PRO:JAN, UniProtKB:P22301]Homo sapiens (human)

Compounds (1)

CompoundDefinitionClassesRoles
hg-9-91-01HG-9-91-01 : A member of the class of phenylureas that is a potent inhibitor of salt-inducible kinase 2, a potential target protein for therapy in ovarian cancer.

HG-9-91-01: inhibits salt-inducible kinases; structure in first source
aminopyrimidine;
dimethoxybenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas;
secondary amino compound
antineoplastic agent;
salt-inducible kinase 2 inhibitor